Likewise, TP53-mutated cancers have been associated with a decrease in the ratio of pro- vs. anti-inflammatory cytokines and downregulation of numerous immune activating mechanisms such as antigen processing and presentation [47]. This evidence concerns the gene TP53 and cancer.